Effects of a Dietary Fibre Supplementation of a Low Calorie Diet on Appetite and Body Weight
Study Details
Study Description
Brief Summary
This 18 week, randomized, double blind, placebo controlled trial will examine the effects of thick dietary fibre (PGX) supplementation of a low calorie diet (LCD) on appetite, weight loss, body composition, and compliance in overweight and moderately obese female.
The investigators believe that 15 grams/day PGX supplementation of a low calorie diet over a 14-weeks period will elicit a better appetite score (e.g. reduced hunger) compared to the rice flour supplementation of the LCD.
Condition or Disease | Intervention/Treatment | Phase |
---|---|---|
|
Phase 3 |
Study Design
Arms and Interventions
Arm | Intervention/Treatment |
---|---|
Experimental: PolyGlycopleX (PGX)
|
Dietary Supplement: PolyGlycopleX (PGX)
The full dose of the study intervention is 15 grams per day and total number of calories with the LCD is 1000 kcal/day.
|
Placebo Comparator: Rice Flour
|
Dietary Supplement: Rice flour
The full dose of the placebo comparator is 15 grams per day and total number of calories with the LCD is 1000 kcal/day.
|
Outcome Measures
Primary Outcome Measures
- The difference in appetite score assessed from appetite Visual Analog Scale [18 weeks]
Secondary Outcome Measures
- Change in weight (kilograms) [18 weeks]
- Change in percentage of body fat [18 weeks]
Eligibility Criteria
Criteria
Inclusion Criteria:
- BMI 25 - 35 Kg/m2
Exclusion Criteria:
-
Medications and supplements that affect appetite
-
Known diabetes
-
Contraindications to LCD
-
Any other medical, social or geographic condition, which, in the opinion of the investigator would not allow safe completion of the protocol.
Contacts and Locations
Locations
Site | City | State | Country | Postal Code | |
---|---|---|---|---|---|
1 | Canadian Center for Functional Medicine | Coquitlam | British Columbia | Canada | V3K 6Y7 |
2 | Canadian Center for Functional Medicine | Coquitlam | British Columbia | Canada |
Sponsors and Collaborators
- Canadian Center for Functional Medicine
- University of British Columbia
- InovoBiologic Inc.
Investigators
- Principal Investigator: Michael R Lyon, M.D., Canadian Center for Functional Medicine
Study Documents (Full-Text)
None provided.More Information
Publications
None provided.- PGX RCT Study